168 related articles for article (PubMed ID: 11034070)
21. Modulation of apoptosis, tumorigenesity and metastatic potential with antisense H-ras oligodeoxynucleotides in a high metastatic tumor model of hepatoma: LCI-D20.
Liao Y; Tang ZY; Ye SL; Liu KD; Sun FX; Huang Z
Hepatogastroenterology; 2000; 47(32):365-70. PubMed ID: 10791191
[TBL] [Abstract][Full Text] [Related]
22. The nitroreductase/CB1954 combination in Epstein-Barr virus-positive B-cell lines: induction of bystander killing in vitro and in vivo.
Westphal EM; Ge J; Catchpole JR; Ford M; Kenney SC
Cancer Gene Ther; 2000 Jan; 7(1):97-106. PubMed ID: 10678362
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
[TBL] [Abstract][Full Text] [Related]
24. Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model.
Cotter FE; Johnson P; Hall P; Pocock C; al Mahdi N; Cowell JK; Morgan G
Oncogene; 1994 Oct; 9(10):3049-55. PubMed ID: 8084613
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity of Epstein-Barr virus-induced B cell tumor to apoptosis mediated by anti-CD95/Apo-1/fas antibody.
Durandy A; Le Deist F; Emile JF; Debatin K; Fischer A
Eur J Immunol; 1997 Feb; 27(2):538-43. PubMed ID: 9045928
[TBL] [Abstract][Full Text] [Related]
26. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.
Uchida T; Gao JP; Wang C; Satoh T; Itoh I; Muramoto M; Hyodo T; Irie A; Akahoshi T; Jiang SX; Kameya T; Baba S
Mol Urol; 2001; 5(2):71-8. PubMed ID: 11690551
[TBL] [Abstract][Full Text] [Related]
27. Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells.
Noguchi T; Ikeda K; Yamamoto K; Yoshida I; Ashiba A; Tsuchiyama J; Shinagawa K; Yoshino T; Takata M; Harada M
Br J Haematol; 2001 Jul; 114(1):84-92. PubMed ID: 11472349
[TBL] [Abstract][Full Text] [Related]
28. Antisense to the epstein-barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) suppresses LMP-1 and bcl-2 expression and promotes apoptosis in EBV-immortalized B cells.
Kenney JL; Guinness ME; Curiel T; Lacy J
Blood; 1998 Sep; 92(5):1721-7. PubMed ID: 9716601
[TBL] [Abstract][Full Text] [Related]
29. SCID/human mouse model of central nervous system lymphoproliferative disease.
Bashir R; Okano M; Kleveland K; Pirrucello S; Masih A; Sanger W; Fordyce-Boyer R; Purtilo D
Lab Invest; 1991 Dec; 65(6):702-9. PubMed ID: 1684402
[TBL] [Abstract][Full Text] [Related]
30. Evolution of clonality and invasive behavior of Epstein-Barr virus immortalized lymphoblastoid cell lines in SCID mice brains.
Bashir R; Masih A; Kallweit K; Fordyce-Boyer R; Sanger W; Purtilo D
Lab Invest; 1992 Oct; 67(4):450-6. PubMed ID: 1331608
[TBL] [Abstract][Full Text] [Related]
31. Human immunoglobulin preparations suppress the occurrence of Epstein-Barr virus-associated lymphoproliferation.
Nadal D; Guzman J; Fröhlich S; Braun DG
Exp Hematol; 1997 Mar; 25(3):223-31. PubMed ID: 9091298
[TBL] [Abstract][Full Text] [Related]
32. Role of IL-6 in promoting growth of human EBV-induced B-cell tumors in severe combined immunodeficient mice.
Durandy A; Emilie D; Peuchmaur M; Forveille M; Clement C; Wijdenes J; Fischer A
J Immunol; 1994 Jun; 152(11):5361-7. PubMed ID: 8189054
[TBL] [Abstract][Full Text] [Related]
33. [Epstein-Barr-virus-induced lymphoproliferative diseases].
Schuster V; Kreth HW
Monatsschr Kinderheilkd; 1991 Jul; 139(7):396-400. PubMed ID: 1656248
[TBL] [Abstract][Full Text] [Related]
34. The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders.
Majewski M; Korecka M; Kossev P; Li S; Goldman J; Moore J; Silberstein LE; Nowell PC; Schuler W; Shaw LM; Wasik MA
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4285-90. PubMed ID: 10759564
[TBL] [Abstract][Full Text] [Related]
35. Human B-cell lymphoma in severe combined immunodeficient mice after active infection with Epstein-Barr virus.
Boyle TJ; Tamburini M; Berend KR; Kizilbash AM; Borowitz MJ; Lyerly HK
Surgery; 1992 Aug; 112(2):378-86. PubMed ID: 1322566
[TBL] [Abstract][Full Text] [Related]
36. BHRF1 antisense oligonucleotide inhibits anti-apoptosis of nasopharyngeal carcinoma cells.
Huang H; Pan X; Zhou J
Int J Mol Med; 1999 Dec; 4(6):649-53. PubMed ID: 10567678
[TBL] [Abstract][Full Text] [Related]
37. HIV-1 induces down-regulation of bcl-2 expression and death by apoptosis of EBV-immortalized B cells: a model for a persistent "self-limiting" HIV-1 infection.
De Rossi A; Ometto L; Roncella S; D'Andrea E; Menin C; Calderazzo F; Rowe M; Ferrarini M; Chieco-Bianchi L
Virology; 1994 Jan; 198(1):234-44. PubMed ID: 8259659
[TBL] [Abstract][Full Text] [Related]
38. Detection of clonal EBV episomes in lymphoproliferations as a diagnostic tool.
Langerak AW; Moreau E; van Gastel-Mol EJ; van der Burg M; van Dongen JJ
Leukemia; 2002 Aug; 16(8):1572-3. PubMed ID: 12145705
[No Abstract] [Full Text] [Related]
39. hu-PBL-SCID mice: an in vivo model of Epstein-Barr virus-dependent lymphoproliferative disease.
Fuzzati-Armentero MT; Duchosal MA
Histol Histopathol; 1998 Jan; 13(1):155-68. PubMed ID: 9476646
[TBL] [Abstract][Full Text] [Related]
40. T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice.
Coles RE; Boyle TJ; DiMaio JM; Berend KR; Via DF; Lyerly HK
Ann Surg Oncol; 1994 Sep; 1(5):405-10. PubMed ID: 7531601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
